Synthesis, crystal structure determination, Hirshfeld surface and crystal void analyses, inter-action energy calculations and energy frameworks of <i>N</i>-(2-chloro-phen-yl)-<i>N</i>'-propano-ylthio-urea. [PDF]
Kumar S, Hökelek T.
europepmc +1 more source
Broadening applications for intrathecal gene therapy: a case for lysosomal storage diseases. [PDF]
eBioMedicine.
europepmc +1 more source
Naturally occurring lysosomal storage disease consistent with neuronal ceroid lipofuscinosis in a group of 5 related captive rhesus macaques (<i>Macaca mulatta</i>). [PDF]
Olstad K +5 more
europepmc +1 more source
Analysis of combinatorial cohesin subunit gene deletions in budding yeast. [PDF]
Duke G, Skibbens RV.
europepmc +1 more source
Benchmarking Nanopore Sequencing for CLN2 (TPP1) Mutation Detection: Integrating Rapid Genomics and Orthogonal Validation for Precision Diagnostics. [PDF]
Teker B +14 more
europepmc +1 more source
Engineering robust <i>Saccharomyces cerevisiae</i> cell factory for improving fatty alcohol biosynthesis. [PDF]
Kong S, Yu W, Wu Z, Gao N, Zhou YJ.
europepmc +1 more source
High-throughput investigation of cyclin docking interactions reveals the complexity of motif binding determinants. [PDF]
Örd M +10 more
europepmc +1 more source
Novel surgical approach for intraventricular cerliponase alfa enzyme replacement therapy via central venous access device (CVAD) port in neuronal ceroid lipofuscinosis type 2 (CLN2) disease. [PDF]
Boop S +8 more
europepmc +1 more source
Crystal structures of (<i>S</i>)-(-)-1-(4-chloro-phen-yl)-<i>N</i>-[(pyridin-2-yl)methyl-idene]ethan-1-amine and its <i>cis</i>-di-chlorido-{(<i>S</i>)-(-)-1-(4-chloro-phen-yl)-<i>N</i>-[(pyridin-2-yl)methyl-idene]ethan-1-amine}palladium(II) complex. [PDF]
Pacheco-Álvarez T +6 more
europepmc +1 more source
2-Amino-5-chloro-pyridin-1-ium barbiturate dihydrate. [PDF]
Anantheeswary TR +3 more
europepmc +1 more source

